Enumera Molecular, Inc.

ANN ARBOR, MI · Founded 2022 · Medtech · Private

Automated molecular diagnostic platform for complex laboratory testing

Claim this profile

Follows are private to you and power your alerts

Updated · enumeramolecular.com

Sector
Medtech
Headquarters
ANN ARBOR, MI
Founded
2022
Latest Form D
$16M, May 2022
Total capital
$16M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$16M
1 Form D · last May 2022
53 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
7 pending · first 2023
Rank in peer group#12 of 73

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $16M1st Form D$16M
2022FEDERAL ↑EQUITY ↓Cumulative $16M1st Form D$16M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$16M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 73 peers

Line = median

Medtech · Platform

  • Granted patents#12 · top 16%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Matthew CooperExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 13
Show all 13 patent records
  • LumeNXT LLCSimilar federal contract value in Medtech · null in contracts
  • CORAMI LLCSimilar federal contract value in Medtech · null in contracts
  • IR Medtek LLCSimilar federal contract value in Medtech · null in contracts
  • Dragonfly Endoscopy Inc.Similar federal contract value in Medtech · null in contracts
  • Magvation Inc.Similar federal contract value in Medtech · null in contracts
  • LightningCath, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .